HTA Database - Search Results

Sort by Relevance

Search Results [628 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Medical Services Advisory Committee (MSAC)	Optical coherence tomography, for the diagnosis and monitoring of treatment effectiveness with aflibercept in patients with central retinal vein occlusion (co-dependent)
2013	Medical Services Advisory Committee (MSAC)	Capsule endoscopy for the diagnosis of suspected small bowel Crohn disease
2013	NIHR Health Technology Assessment programme	Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling
2013	NIHR Health Technology Assessment programme	The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013	NIHR Health Technology Assessment programme	A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression
2013	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of new-generation computed tomography scanners for imaging in coronary artery disease and congenital heart disease: Somatom Definition Flash, Aquilion ONE, Brilliance iCT and Discovery CT750 HD
2013	NIHR Health Technology Assessment programme	Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis
2013	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer
2013	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2013	Scottish Health Technologies Group (SHTG)	Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with melanoma yield clinical and economic benefits?
2013	Scottish Health Technologies Group (SHTG)	Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with sarcoidosis yield clinical and economic benefits?
2013	Scottish Health Technologies Group (SHTG)	What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2013	Scottish Health Technologies Group (SHTG)	PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2013	HAYES, Inc.	Low-dose helical (spiral) computed tomography for lung cancer screening
2013	HAYES, Inc.	Radioiodinated metaiodobenzylguanidine (131I-MIBG) targeted radiation therapy for refractory or relapsed neuroblastoma
2013	Blue Cross Blue Shield Association (BCBS)	Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness and safety of MRI 3 tesla versus MRI 1.5 tesla. Systematic Review]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for clinical interventions: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Biologic response modifier agents as first-line treatment for patients with rheumatoid arthritis: a review of the clinical efficacy, cost-effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography guided versus ultrasound guided renal biopsy: comparative evidence
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital tomosynthesis for the diagnosis of breast cancer]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[MRI enterography for the assessment of inflammatory bowel disease]
2013	HAYES, Inc.	Musculoskeletal ultrasonography for diagnosis of low back pain
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke: a review of comparative clinical evidence and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Multi-dose contrast media for patients undergoing computed tomography: clinical benefits, harms, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
2013	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Evaluation of efficacy and safety of PET-CT (update)]
2013	Malaysian Health Technology Assessment (MaHTAS)	Autologous peripheral blood stem cells for articular cartilage repair
2013	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis of the status, systematic review and validation of a diagnostic algorithm for pulmonary thromboembolism (PTE) in the hospital emergency services of the Basque Health Service]
2013	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Prevention of nephropathy by iodinated contrast media during a radiological intervention]
2012	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model
2012	NIHR Health Technology Assessment programme	EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation
2012	HAYES, Inc.	Coronary artery calcium scoring to assess the risk of coronary artery disease in asymptomatic adults
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diagnosis and treatment of pineal gland cysts: a review of the clinical effectiveness and guidelines
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
2012	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Role of PET/CT with choline analogue radiotracers in the diagnosis and staging of prostate cancer]
2012	HAYES, Inc.	Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
2012	HAYES, Inc.	Statscan critical imaging system (Lodox Systems (Pty) Ltd.) for evaluation of patients with trauma or injury
2012	Agency for Healthcare Research and Quality (AHRQ)	Noninvasive diagnostic tests for breast abnormalities: update of a 2006 review
2012	HAYES, Inc.	Musculoskeletal ultrasound for rheumatoid arthritis
2012	HAYES, Inc.	Cirrus HD-OCT (Carl Zeiss Meditec Inc.) for diagnosis of glaucoma
2012	HAYES, Inc.	EarlyCDT-lung risk assessment test (Oncimmune [USA] LLC)
2012	HAYES, Inc.	O-arm imaging system (Medtronic Inc.) for guiding pedicle screw placement in thoracic and lumbosacral spinal surgery
2012	HAYES, Inc.	Panexia test for hereditary pancreatic cancer
2012	Blue Cross Blue Shield Association (BCBS)	Beta amyloid imaging with Positron Emission Tomography (PET) for evaluation of suspected alzheimer's disease or other causes of cognitive decline
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A systematic review of the diagnostic accuracy of FDG PET/PET-CT for fever of unknown origin]
2012	Agenzia nazionale per i servizi sanitari regionali (Agenas)	FDG-PET/CT for cancer staging
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias]
2012	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in lung cancer
2012	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in malignant lymphoma: Hodgkin's lymphoma, aggressive non-Hodgkin's lymphoma
2012	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for the appropriate use of positron emission tomography with FDG (FDG-PET) in head and neck cancer
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Indications and recommendations for the use of PET-CT in the planning of radiation oncology treatment. Systematic review]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2012	Canary Health Service	[Systematic review of the economic impact of MRI-guided surgery (update)]
2011	NIHR Health Technology Assessment programme	Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation
2011	NIHR Health Technology Assessment programme	The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2011	Committee for New Health Technology Assessment (CNHTA)	[Intraoperative Radiotherapy with Low Energy X-rays]
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Indications for positron emission tomography (pet): a brief update]
2011	HAYES, Inc.	Positron Emission Tomography (PET) for alzheimer's disease
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Real time intraoperative magnetic resonance imaging monitoring]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Feeding tube verification procedures: optimal timing and guidelines
2011	HAYES, Inc.	Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx) for mammography
2011	HAYES, Inc.	NOD2/CARD15 testing for crohn's disease
2011	HAYES, Inc.	Dentatorubral-Pallidoluysian Atrophy (DRPLA)
2011	HAYES, Inc.	Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011	HAYES, Inc.	Intraoperative Radiation Therapy (IORT) for breast cancer
2011	HAYES, Inc.	Percutaneous transcatheter coil embolization for Pelvic Congestion Syndrome (PCS)
2011	HAYES, Inc.	Computer-aided detection of pulmonary embolism
2011	HAYES, Inc.	Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2011	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Shoulder pain: appropriateness use of diagnostic imaging tests]
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in esophageal cancer
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in colorectal cancer
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in breast cancer
2011	Haute Autorite de sante (HAS)	[MRI-guided vacuum-assisted breast biopsy (VABB)]
2011	Canary Health Service	[Variations, inequalities, degree of inappropriate use and avoidable costs of imaging tests in the diagnosis and follow-up of stroke patients in the Canary Islands]
2010	VA Technology Assessment Program (VATAP)	Gadolinium-containing contrast agents for patients with renal disease
2010	NIHR Health Technology Assessment programme	A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2010	HTA Database, Centre for Reviews and Dissemination, University of York (CRD)	Transarterial chemoembolization for palliation of unresectable liver metastases from colorectal cancer (Protocol for a systematic review)
2010	HTA Database, Centre for Reviews and Dissemination, University of York (CRD)	The effectiveness of exercise in the physiotherapy management of subacromial impingement syndrome (Protocol for a systematic review)
2010	HTA Database, Centre for Reviews and Dissemination, University of York (CRD)	Correlations of P16 CpG Island Methylation to Carcinogenesis of Hepatocellular Carcinoma (Protocol for a systematic review)
2010	HAYES, Inc.	Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010	HAYES, Inc.	Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010	HAYES, Inc.	Positron emission tomography (PET) and combined positron emission tomography-computed tomography (PET-CT) for breast cancer detection
2010	Medical Advisory Secretariat (MAS)	Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010	Medical Services Advisory Committee (MSAC)	Assessment of liver iron by R2 - Medical Resonance Imaging (MRI) data analysis
2010	Adelaide Health Technology Assessment (AHTA)	Screening for lung cancer utilising computed tomography (CT)
2010	Adelaide Health Technology Assessment (AHTA)	Scintimammograms or breast-specific gamma imaging (BSGI) for the evaluation of disease spread in women diagnosed with breast cancer
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[Biologics for early rheumatoid arhritis]
2010	Blue Cross Blue Shield Association (BCBS)	Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Chronic low back pain: the appropriate use of diagnostic imaging procedures]